We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $8.21B
1-Year Est. Return 28.81%
This Fund
S&P 500
This Quarter Est. Return
+0.27%
1 Year Est. Return
+28.81%
3 Year Est. Return
+92.54%
5 Year Est. Return
+114.67%
10 Year Est. Return
+429.8%
AUM
$3.59B
AUM Growth
-$78.5M
Cap. Flow
-$53.5M
Cap. Flow %
-1.49%
Top 10 Hldgs %
13.47%
Holding
1,643
New
159
Increased
579
Reduced
611
Closed
173

Top Buys

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$52.5M
2
AFL icon
Aflac
AFL
+$24.1M
3
WLY icon
John Wiley & Sons Class A
WLY
+$18.9M
4
KMX icon
CarMax
KMX
+$17.5M
5
BIIB icon
Biogen
BIIB
+$16.9M

Sector Composition

Rank Sector Weight
1 Healthcare 15.39%
2 Energy 10.37%
3 Financials 10.35%
4 Technology 9.89%
5 Industrials 9.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MDT icon
51
Medtronic
MDT
$110B
$14.4M 0.4%
193,702
+3,595
+2% +$275K
GHL
52
DELISTED
Greenhill & Co., Inc.
GHL
$14.2M 0.4%
344,677
+308,353
+849% +$12.5M
AGN
53
DELISTED
Allergan plc
AGN
$14M 0.39%
46,014
+2,723
+6% +$812K
EHC icon
54
Encompass Health
EHC
$11B
$13.7M 0.38%
374,492
-33,579
-8% -$1.2M
ORLY icon
55
O'Reilly Automotive
ORLY
$72.4B
$13.2M 0.37%
873,060
-3,525
-0.4% -$52.3K
CELG
56
DELISTED
Celgene Corp
CELG
$13M 0.36%
112,452
-2,553
-2% -$292K
AIG icon
57
American International
AIG
$41.8B
$12.8M 0.36%
206,932
-28,978
-12% -$1.71M
EPR icon
58
EPR Properties
EPR
$4.9B
$12.2M 0.34%
222,523
+2,763
+1% +$161K
F icon
59
Ford
F
$59.3B
$12.2M 0.34%
812,019
-148,426
-15% -$2.3M
EOG icon
60
EOG Resources
EOG
$77.5B
$11.7M 0.32%
133,260
-4,735
-3% -$438K
ABBV icon
61
AbbVie
ABBV
$455B
$11.5M 0.32%
170,522
+9,038
+6% +$590K
MDY icon
62
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$26.6B
$11.4M 0.32%
41,759
-40,194
-49% -$11.2M
WFC icon
63
Wells Fargo
WFC
$258B
$11.3M 0.31%
200,767
+13,352
+7% +$744K
HON icon
64
Honeywell
HON
$76.7B
$11.3M 0.31%
123,179
+10,144
+9% +$946K
VFC icon
65
VF Corp
VFC
$5.87B
$11.2M 0.31%
171,026
+3,977
+2% +$269K
SMCI icon
66
Super Micro Computer
SMCI
$17.9B
$11.2M 0.31%
3,786,400
+1,816,170
+92% +$5.98M
NVO
67
Novo Nordisk
NVO
$228B
$11M 0.31%
402,752
-3,000
-0.7% -$84.3K
SWKS icon
68
Skyworks Solutions
SWKS
$9.4B
$11M 0.31%
105,807
+21,370
+25% +$2.16M
BP icon
69
BP
BP
$114B
$11M 0.31%
326,065
+16,878
+5% +$591K
OXY icon
70
Occidental Petroleum
OXY
$55.6B
$11M 0.31%
141,207
+14,147
+11% +$1.11M
AXP icon
71
American Express
AXP
$228B
$10.9M 0.3%
139,687
-1,647
-1% -$131K
PM icon
72
Philip Morris
PM
$299B
$10.8M 0.3%
135,321
+8,872
+7% +$730K
LOW icon
73
Lowe's Companies
LOW
$118B
$10.6M 0.3%
158,539
+6,170
+4% +$440K
EFA icon
74
iShares MSCI EAFE ETF
EFA
$78.5B
$10.2M 0.28%
160,004
-257,826
-62% -$17.2M
PWR icon
75
Quanta Services
PWR
$98.7B
$9.99M 0.28%
346,749
-2,903
-0.8% -$84.9K

Similar funds

Oppenheimer & Co's Q2 2015 Portfolio in Review

As of Q2 2015, Oppenheimer & Co held 1,643 positions worth $3.59B, down 2.1% from $3.67B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Oppenheimer & Co's Q2 2015 filing shows 159 new, 579 increased, 611 reduced and 173 closed positions. Its largest new stake was Southwestern Energy Company: 251,114 shares worth $5.71M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $70.4M.

By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 12% a quarter earlier, followed by Energy and Financials.

  • Oppenheimer & Co's largest Q2 2015 buy was Southwestern Energy Company: 251,114 shares worth $5.71M.
  • Oppenheimer & Co added most to Gilead Sciences in Q2 2015, an estimated $52.5M increase.
  • Oppenheimer & Co's biggest Q2 2015 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $70.4M.
  • Oppenheimer & Co fully exited Vanguard Total Bond Market in Q2 2015, selling an estimated $12.6M.
  • Oppenheimer & Co's ten largest holdings make up 13% of its $3.59B portfolio in Q2 2015.
  • Oppenheimer & Co opened 159 new positions and closed 173 in Q2 2015.
  • Oppenheimer & Co's portfolio value fell 2.1% quarter-over-quarter to $3.59B.

Based on Oppenheimer & Co's 13F filing for Q2 2015, filed 12 Aug 2015.